Wedbush Securities Inc. raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,992 shares of the medical equipment provider’s stock after buying an additional 53 shares during the quarter. Wedbush Securities Inc.’s holdings in Intuitive Surgical were worth $4,724,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of ISRG. Merit Financial Group LLC grew its position in Intuitive Surgical by 8.8% during the fourth quarter. Merit Financial Group LLC now owns 779 shares of the medical equipment provider’s stock worth $461,000 after buying an additional 63 shares in the last quarter. Reilly Financial Advisors LLC grew its position in Intuitive Surgical by 121.3% during the fourth quarter. Reilly Financial Advisors LLC now owns 166 shares of the medical equipment provider’s stock worth $98,000 after buying an additional 91 shares in the last quarter. Sciencast Management LP purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $1,168,000. AE Wealth Management LLC boosted its holdings in shares of Intuitive Surgical by 16.9% in the 4th quarter. AE Wealth Management LLC now owns 1,531 shares of the medical equipment provider’s stock worth $905,000 after purchasing an additional 221 shares in the last quarter. Finally, Calamos Wealth Management LLC boosted its holdings in shares of Intuitive Surgical by 2.1% in the 4th quarter. Calamos Wealth Management LLC now owns 884 shares of the medical equipment provider’s stock worth $523,000 after purchasing an additional 18 shares in the last quarter. Hedge funds and other institutional investors own 85.59% of the company’s stock.
In related news, EVP Curet Myriam sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $553.54, for a total transaction of $1,660,620.00. Following the completion of the transaction, the executive vice president now owns 3,851 shares of the company’s stock, valued at approximately $2,131,682.54. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Marshall Mohr sold 7,500 shares of the firm’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,113,225.00. Following the transaction, the chief financial officer now directly owns 20,135 shares of the company’s stock, valued at approximately $11,042,638.05. The disclosure for this sale can be found here. Insiders sold a total of 25,319 shares of company stock valued at $14,351,365 in the last three months. Corporate insiders own 1.70% of the company’s stock.
ISRG traded up $1.05 during midday trading on Thursday, reaching $598.29. 498,910 shares of the company’s stock traded hands, compared to its average volume of 710,546. The firm has a fifty day moving average of $590.28 and a two-hundred day moving average of $545.03. The stock has a market capitalization of $69.14 billion, a price-to-earnings ratio of 63.04, a P/E/G ratio of 4.50 and a beta of 1.12. Intuitive Surgical, Inc. has a 52 week low of $455.15 and a 52 week high of $616.56.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $3.43 EPS for the quarter, beating analysts’ consensus estimates of $2.99 by $0.44. Intuitive Surgical had a return on equity of 18.26% and a net margin of 30.94%. The business had revenue of $1.13 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the prior year, the company posted $2.83 EPS. Intuitive Surgical’s quarterly revenue was up 22.5% compared to the same quarter last year. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 11.01 earnings per share for the current fiscal year.
ISRG has been the subject of a number of research reports. Royal Bank of Canada set a $570.00 price objective on Intuitive Surgical and gave the stock a “hold” rating in a report on Friday, October 18th. Wells Fargo & Co restated an “overweight” rating and set a $655.00 target price (up from $620.00) on shares of Intuitive Surgical in a report on Monday, December 9th. Morgan Stanley increased their target price on Intuitive Surgical from $620.00 to $670.00 and gave the company an “overweight” rating in a report on Tuesday, December 17th. Oppenheimer assumed coverage on Intuitive Surgical in a report on Wednesday, November 20th. They set a “market perform” rating for the company. Finally, Raymond James increased their target price on Intuitive Surgical from $610.00 to $625.00 and gave the company a “buy” rating in a report on Friday, October 18th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and twelve have given a buy rating to the company. Intuitive Surgical has an average rating of “Buy” and a consensus price target of $605.31.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: Profit Margin
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.